
Sun Pharma shares in focus after US FDA issues eight observations for Halol facility
Sun Pharma shares will be in focus on Monday after the company announced that the U.S. Food and Drug Administration (FDA) issued a Form-483 with eight observations for its Halol facility. The observations followed a Good Manufacturing Practices (GMP) …